NCT00542165View on ClinicalTrials.gov

Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy

PHASE4CompletedINTERVENTIONAL

Enrollment

166

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

December 31, 2004

Conditions

BPH/LUTS/Sexual Functions

Interventions

DRUG

Alfuzosin

Trial Locations (1)

Unknown

Sanofi-Aventis, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00542165 - Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy | Biotech Hunter | Biotech Hunter